United Kingdom

People: Merck & Co Inc (MRK.N)

MRK.N on New York Stock Exchange

19 Jul 2019
Change (% chg)

$-1.30 (-1.57%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chattopadhyay, Sanat 

Mr. Sanat Chattopadhyay is the Executive Vice President and President - Merck Manufacturing Division of the Company. He joined Merck in 2009 and currently serves as senior vice president of Global Manufacturing Operations (Human Health). He was instrumental in transforming Merck Vaccines' manufacturing and supply to grow and globalize the company's vaccines business. Chattopadhyay also played a key part in leading the company's launch of KEYTRUDA (pembrolizumab) in record time by mobilizing a cross-divisional effort to overcome commercialization and supply constraints.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --